It’s Linky Sunday – put on the coffee and prepare your cursor :)
We’ve gathered up some of the week’s best stories from around the web.
Movies for grown-ups. With younger people preferring to stream films online than spend money at the theater, USA Today says movie studios are starting to recognize the value of filmgoers 50-plus, who still like to go out and see movies on the big screen as soon as they come out. The result: more and better movies for grown-ups. Click here to read more.
It’s the salt, silly! Why have scientists waited until now to ask whether lowering salt intake lowers blood pressure in older people? In a recently published study, lowering salt to below the upper limit of the current recommended daily allowance brought blood pressure down to normal in a group of 60- to 80-year-olds even after they tapered off their anti-hypertensive meds. Click here to read more.
A working retirement? U.S. News a& World Report has done the byzantine math on what happens to your benefits when you work close to or after the retirement age, and depending on how much you make. Click here to get the scoop.
Fashion tips from seniors. Buzzfeed, a mega-popular blog for 20- and 30-somethings that we’ve called out in the past for ageism, did a nice job last week of showing its readers what they can learn about stylish dressing from women and men many years their senior. Senior style tip #1, according to Buzzfeed: “Forget what anyone thinks and do what makes YOU happy!” Click here to see “18 Fabulous Style Tips From Senior Citizens” and leave a comment on Buzzfeed’s page to say thanks for breaking the boundaries.
You’re never too old for a shrink. Used to be, being depressed meant you were weak and seeing a psychologist meant you were crazy. That was a long time ago and these days, seniors of all ages are seeing shrinks in ever-larger numbers, according to the New York Times science blog. Click here to read more and click here to hear directly from three seniors abut their experiences in therapy.
Xeljanz an FDA fail? Pfizer’s Arthritis Drug Xeljanz, which the FDA approved last year, was rejected last week by Europe’s Committee for Medicinal Products for Human Use. The committee ruled that the drug’s questionable benefits did not outweigh real risks. Click here to read more.
Your Sunday LOL
Happy clicking, and enjoy your Sunday!